gadobutrol
NDC 70436-218, gadobutrol, injection, from Slate Run Pharmaceuticals, LLC.
- Product NDC
- 70436-218
- Status
- Listed
- Labeler
- Slate Run Pharmaceuticals, LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217480
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70436-218 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GADOBUTROL604.72 mg/mL
Pharmacologic classes
Gadolinium-based Contrast Agent [EPC]; Magnetic Resonance Contrast Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70436-218-84 | 70436021884 | 3 VIAL, SINGLE-DOSE in 1 CARTON (70436-218-84) / 2 mL in 1 VIAL, SINGLE-DOSE (70436-218-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/832e0ae1-4fe1-4dff-9978-c9200bcebb55
Use it
Look up 70436-218 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70436-218 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70436-218. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.